Quality and reporting accuracy of phase 1 drug radiation clinical trials

Hyun Kim; Tu D. Dan; Joshua D. Palmer; Benjamin E. Leiby; Yaacov R. Lawrence; Adam P. Dicker

doi:10.1001/jamaoncol.2015.4833

Quality and reporting accuracy of phase 1 drug radiation clinical trials

Hyun Kim
, Tu D. Dan
, Joshua D. Palmer
, Benjamin E. Leiby
, Yaacov R. Lawrence
, Adam P. Dicker

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	390-391
Number of pages	2
Journal	JAMA oncology
Volume	2
Issue number	3
DOIs	https://doi.org/10.1001/jamaoncol.2015.4833
State	Published - Mar 2016

Access to Document

10.1001/jamaoncol.2015.4833

Cite this

@article{c118823fb7b7412a832a36c718fed204,

title = "Quality and reporting accuracy of phase 1 drug radiation clinical trials",

author = "Hyun Kim and Dan, \{Tu D.\} and Palmer, \{Joshua D.\} and Leiby, \{Benjamin E.\} and Lawrence, \{Yaacov R.\} and Dicker, \{Adam P.\}",

note = "Funding Information: Dr Leiby is supported in part by award No. P30 CA056036-16 from the National Cancer Institute (NCI). Dr Lawrence is supported in part by EU FP7 Marie-Curie funding (CIG PCIG10-GA-2011-303795). The NCI and Marie-Curie funding had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.",

year = "2016",

month = mar,

doi = "10.1001/jamaoncol.2015.4833",

language = "English",

volume = "2",

pages = "390--391",

journal = "JAMA oncology",

issn = "2374-2437",

number = "3",

}

TY - JOUR

T1 - Quality and reporting accuracy of phase 1 drug radiation clinical trials

AU - Kim, Hyun

AU - Dan, Tu D.

AU - Palmer, Joshua D.

AU - Leiby, Benjamin E.

AU - Lawrence, Yaacov R.

AU - Dicker, Adam P.

N1 - Funding Information: Dr Leiby is supported in part by award No. P30 CA056036-16 from the National Cancer Institute (NCI). Dr Lawrence is supported in part by EU FP7 Marie-Curie funding (CIG PCIG10-GA-2011-303795). The NCI and Marie-Curie funding had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

PY - 2016/3

Y1 - 2016/3

UR - https://www.scopus.com/pages/publications/84979517956

U2 - 10.1001/jamaoncol.2015.4833

DO - 10.1001/jamaoncol.2015.4833

M3 - Letter

C2 - 26841256

AN - SCOPUS:84979517956

SN - 2374-2437

VL - 2

SP - 390

EP - 391

JO - JAMA oncology

JF - JAMA oncology

IS - 3

ER -

Quality and reporting accuracy of phase 1 drug radiation clinical trials

Access to Document

Other files and links

Cite this